Physician profile
Sunil P Sinha
NPI 1720271562
$12,214.77
in general payments reported to CMS, 2019-2025
8 companies · $3,260 in 2025
The $3,260 reported for 2025 was more than what 94% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,616 · 2021: $460 · 2022: $701 · 2023: $3,684 · 2024: $1,493 · 2025: $3,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,969 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,907 · Consulting Fee: $1,500 · Education: $500 · Gift: $283 · Travel and Lodging: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,969.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,907.00 |
| Consulting Fee | $1,500.00 |
| Education | $500.00 |
| Gift | $282.97 |
| Travel and Lodging | $278.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $7,514.85 | 2019-2025 | |
| Biohorizons Implant Systems INC. | $3,927.95 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Nobel Biocare USA | $404.21 | 2019-2023 | Nobelactive |
| Depuy Synthes Sales INC. | $198.91 | 2019-2024 | Trumatch |
| Pacira Pharmaceuticals Incorporated | $104.42 | 2022-2025 | Exparel |
| Henry Schein, INC. | $52.43 | 2019 | |
| Kls-Martin L.P. | $12.00 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$339,131.42 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.